The Cooper Companies with ticker code (COO) now have 12 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 560 and 310 and has a mean target at 407.58. Given that the stocks previous close was at 293.51 this indicates there is a potential upside of 38.9%. The day 50 moving average is 323.55 while the 200 day moving average is 383.71. The market capitalisation for the company is $14,512m. Company Website: https://www.coopercos.com
The potential market cap would be $20,152m based on the market concensus.
The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
